Press Releases
Phoenix Accident Doctors Unveils a New Way to End Car Accident Pain Permanently Without Surgery
Phoenix, Arizona, July 02, 2025 (GLOBE NEWSWIRE) -- Dr. Thanh Nguyen of The Accident Doctors AZ has created an innovative platelet treatment that resolves chronic pain with an over 90% success rate by harnessing the body's natural healing abilities. Thoracic pain resolved with PRF treatment Accident victims suffering from chronic pain now have a groundbreaking treatment option that avoids surgery and steroid injections.... ❯❯❯
U.S. Oral Surgery Management Names Doug Drew CEO
Richard Hall to Serve as Chairman of the BoardIRVING, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) developed and implemented a succession plan earlier this year to ensure a smooth transition from long- time CEO, Richard Hall. Hall is transitioning from his role as President and CEO of USOSM to Chairman of the USOSM Board of Directors. Effective July 1, the new CEO is Doug Drew, a seasoned healthcare... ❯❯❯
Extendicare Acquires Closing the Gap Healthcare Group
Extendicare increases Senior Secured Credit Facility to $375 millionMARKHAM, Ontario, July 02, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that its wholly owned home healthcare subsidiary, ParaMed Inc. (“ParaMed” or the “Purchaser”), completed the previously announced acquisition of all of the issued and outstanding shares of Closing the Gap Healthcare Group Inc. and certain... ❯❯❯
AppleGate Recovery Unveils Brand Refresh Aligned with BayMark Health Services Continuum of Care
LEWISVILLE, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- AppleGate Recovery, a leading provider of office-based medication-assisted treatment (MAT) for substance use disorders, is proud to announce the launch of its refreshed brand identity. The update unifies the brand with its parent organization, BayMark Health Services, and its network of treatment providers across the country. This brand refresh includes a modernized logo that... ❯❯❯
Middlesex Recovery Unveils Brand Refresh to Reflect Unified Identity with BayMark Health Services
LEWISVILLE, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- Middlesex Recovery, a provider of office-based opioid treatment for substance use disorders, has introduced a brand refresh that reflects its alignment with BayMark Health Services and its family of programs. The refresh includes a new logo, updated marketing materials, and an enhanced digital presence. These changes are part of the broader effort to reflect Middlesex Recovery's... ❯❯❯
Pennant Announces Home Health Acquisition in Southern California
EAGLE, Idaho, July 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of a premier home health agency, GrandCare Health Services. The newly acquired agency, to be known as GrandCare Home Health, provides services in Los Angeles, Orange, Riverside and San Diego counties in... ❯❯❯
Allarity Therapeutics Receives Australian Patent Acceptance Notice for Stenoparib DRP® Companion Diagnostic
TARPON SPRINGS, Fla., June 30, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor—as a personalized cancer treatment using its proprietary, drug-specific Drug Response Predictor (DRP®) patient selection technology—today announced that IP Australia, the Australian... ❯❯❯
Allarity Therapeutics Announces Dosing of Second Patient in New Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer
TARPON SPRINGS, Fla., June 27, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor today announced that the second patient has been dosed in its new Phase 2 clinical trial protocol evaluating stenoparib in patients with advanced, recurrent, platinum-resistant or... ❯❯❯
Extendicare Announces Renewal of Normal Course Issuer Bid
MARKHAM, Ontario, June 26, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that the Toronto Stock Exchange (the “TSX”) has approved the renewal of Extendicare’s normal course issuer bid (“NCIB”). Under the terms of the NCIB, the Company may purchase for cancellation up to 7,281,193 of its common shares (the “Common Shares”), representing 10% of its public float of issued and... ❯❯❯
Dr. Anosh Ahmed Supports Trump’s Statement on Chicago, Citing Ongoing Public Safety and Policy Challenges
Physician and Republican leader voices concern over rising crime and strained social infrastructure in the city Image by Dr. Anosh Ahmed CHICAGO, June 26, 2025 (GLOBE NEWSWIRE) -- In response to President Donald J. Trump’s recent remarks about conditions in Chicago, Dr. Anosh Ahmed, a Chicago-based physician and businessman, has publicly expressed agreement, citing increasing concerns around public safety, homelessness, and the... ❯❯❯
